MedTrace Logo

Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial

NCT02201641 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2017-03-03

No results posted yet for this study

Summary

This study aims to investigate the tooth nerve response to a recently introduced therapeutic filling material (calcium silicate cement) called Biodentine and to assess the quality of the overlying filling compared to another material (glass ionomer cement) called Fuji IX used more commonly. Also to compare the effectiveness of cone beam computed tomography x-rays compared to conventional periapical x-rays in detecting lesions around these teeth.

Conditions

  • Reversible Pulpitis

Interventions

RADIATION

Cone Beam computed tomography (Morita Accuitomo)

CBCT scans are taken to assess the efficacy of this method in detecting the presence of early peri-radicular lesions.

RADIATION

Periapical radiographs

Periapical radiographs are taken as a control to detect the presence of early peri-radicular lesions.

DEVICE

calcium silicate cement (Biodentine™)

calcium silicate cement (Biodentine™) used for indirect pulp capping of teeth with deep carious lesions and inflammed pulps.

DEVICE

glass ionomer cement ( Fuji IX™)

glass ionomer cement ( Fuji IX™) used for indirect pulp capping of teeth with deep carious lesions and inflammed pulp.

Sponsors & Collaborators

Principal Investigators

  • Timothy F Watson, BDS,MSc,PhD · King's College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02201641 on ClinicalTrials.gov